Alembic Pharma raises Rs 150 crore via non-convertible debentures

New Delhi: Drug firm Alembic Pharmaceuticals Tuesday said it has raised Rs 150 crore through the allotment of non-convertible debentures (NCDs) on private placement basis. These NCDs carry a coupon rate of 8.37 per cent per annum and are proposed to be listed on NSE.

“The NCD Committee of Alembic Pharmaceuticals Ltd at its meeting held today has allotted 1,500, 8.37 per cent unsecured listed rated redeemable NCDs of Rs 10,00,000…aggregating to Rs 150 crore under tranch. III,” the company said in a regulatory filing. Date of maturity of these NCDs is March 18, 2022. Shares of Alembic Pharma were trading 0.53 per cent higher at Rs 542 apiece on BSE.

(For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Free Press Journal